Bank of Nova Scotia Trims Stock Holdings in Healthpeak Properties, Inc. $DOC

Bank of Nova Scotia decreased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 57.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 46,144 shares of the real estate investment trust’s stock after selling 61,885 shares during the period. Bank of Nova Scotia’s holdings in Healthpeak Properties were worth $987,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of DOC. Clearstead Trust LLC increased its position in shares of Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 543 shares in the last quarter. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter valued at approximately $26,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Healthpeak Properties during the second quarter worth $33,000. Clearstead Advisors LLC boosted its stake in Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after buying an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth approximately $31,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $21.54 on Thursday. The company has a market capitalization of $14.85 billion, a price-to-earnings ratio of 61.54, a PEG ratio of 2.36 and a beta of 1.01. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm has a 50-day moving average of $21.48 and a two-hundred day moving average of $19.14.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same quarter last year, the business posted $0.46 EPS. Healthpeak Properties’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.7%. Healthpeak Properties’s payout ratio is presently 348.57%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on DOC shares. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a report on Monday, May 11th. Citigroup raised their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Mizuho increased their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and a consensus price target of $21.66.

View Our Latest Report on Healthpeak Properties

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Featured Articles

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.